Estonian Presidency of the EU has published a ‘Call for Action’ for more investment, bigger impact and more trust in science in the next EU research programme
Public-private drug research programme has - as yet - only provided limited examples of how it is delivering on its goals, an independent evaluation concludes
German tech giant weighs into debate over next EU research programmes, backing idea of creating high-profile technology missions – but with careful planning
An advanced robot that can perform high precision surgery. Automated patient voice analysis as a method for medical diagnosis and individual treatment. Swedish and Japanese researchers can now start to work more closely together in areas like this to tackle the challenges of an ageing population.
Stroke patients with dementia treated with intravenous thrombolysis using powerful clot-busting drugs are at no higher risk of brain haemorrhage or death than other patients receiving the same treatment, a study from Karolinska Institutet published in the journal Neurology reports.
After a campaign by scientists, the Irish government announces membership of European Southern Observatory, operator of some of the biggest telescopes in the world
The Commission has for the first time made clear the position of UK grantees after Brexit, in a sign the EU is laying the ground for the UK to leave without a deal
Employees are lukewarm on new locations and a slow-down in work rate will mean less income. In the best case scenario Europe’s drugs regulator will take 2-3 years to get back to speed after leaving London.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.